Quick Takeaways
- R01 Fund LP filed SCHEDULE 13D for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY).
- Disclosed ownership: 16%.
- Date of event: 09 Oct 2025.
R01 Fund LP - 09 Oct 2025 SCHEDULE 13D Report for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY)
- Filing Manager
- R01 Fund LP
- Reporting Manager
- R01 Fund LP
- Symbol
- NBY
- Shares outstanding
- 7,185,907 shares
- Disclosed Ownership
- 1,164,117 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13D
- Filing time
- 15 Oct 2025, 20:29:07 UTC
- Date of event
- 09 Oct 2025
- Next filing
- 20 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"R01 Fund LP disclosed 16% ownership in NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY) on 09 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Oct 2025, 20:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| R01 Fund LP | 16% | 1,164,117 | 0 | 1,164,117 | /s/ Michael Kazley | Michael Kazley / Principal | 0001990517 |
| R01 Capital LLC | 16% | 1,164,117 | 0 | 1,164,117 | /s/ Michael Kazley | Michael Kazley / Managing Member | |
| R01 Capital Manager LLC | 16% | 1,164,117 | 0 | 1,164,117 | /s/ Michael Kazley | Michael Kazley / Managing Member | |
| Michael Kazley | 16% | 1,164,117 | 0 | 1,164,117 | /s/ Michael Kazley | Michael Kazley |